Corbenic Partners’s CRISPR Therapeutics CRSP Stock Holding History

Corbenic Partners’s Portfolio CRSP Stock Details CRSP Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$1K	Sell
2022 Q1	$4K	Sell
2021 Q4	$55K	Sell
2021 Q3	$86K	Hold
2021 Q2	$124K	Hold
2021 Q1	$93K	Buy